Family Legacy Inc. trimmed its stake in Procter & Gamble Co (NYSE:PG) by 53.2% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 7,687 shares of the company’s stock after selling 8,734 shares during the period. Procter & Gamble makes up about 1.8% of Family Legacy Inc.’s portfolio, making the stock its 27th biggest position. Family Legacy Inc.’s holdings in Procter & Gamble were worth $699,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors also recently bought and sold shares of the company. Asset Planning Services Ltd. lifted its holdings in shares of Procter & Gamble by 0.4% in the 2nd quarter. Asset Planning Services Ltd. now owns 1,191 shares of the company’s stock valued at $104,000 after buying an additional 5 shares during the period. Harding Loevner LP purchased a new position in shares of Procter & Gamble in the 2nd quarter valued at about $119,000. Kohmann Bosshard Financial Services LLC purchased a new position in shares of Procter & Gamble in the 3rd quarter valued at about $125,000. Blume Capital Management Inc. increased its stake in Procter & Gamble by 25.4% during the 2nd quarter. Blume Capital Management Inc. now owns 1,482 shares of the company’s stock worth $129,000 after buying an additional 300 shares in the last quarter. Finally, Litman Gregory Asset Management LLC purchased a new stake in Procter & Gamble during the 3rd quarter worth approximately $173,000. 61.05% of the stock is owned by institutional investors and hedge funds.
In related news, insider Deborah P. Majoras sold 4,591 shares of the business’s stock in a transaction dated Friday, January 26th. The shares were sold at an average price of $87.48, for a total transaction of $401,620.68. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Marc S. Pritchard sold 46,842 shares of the company’s stock in a transaction dated Wednesday, January 24th. The stock was sold at an average price of $89.01, for a total transaction of $4,169,406.42. The disclosure for this sale can be found here. Insiders sold a total of 114,011 shares of company stock worth $9,710,976 in the last quarter. 0.35% of the stock is currently owned by company insiders.
Shares of Procter & Gamble Co (NYSE:PG) traded down $0.74 on Wednesday, hitting $78.98. 6,648,951 shares of the stock were exchanged, compared to its average volume of 9,985,010. The stock has a market cap of $199,150.00, a PE ratio of 20.08, a price-to-earnings-growth ratio of 2.49 and a beta of 0.58. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.79 and a current ratio of 0.94. Procter & Gamble Co has a fifty-two week low of $77.90 and a fifty-two week high of $94.67.
Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Tuesday, January 23rd. The company reported $1.19 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.14 by $0.05. The company had revenue of $17.40 billion for the quarter, compared to analyst estimates of $17.39 billion. Procter & Gamble had a net margin of 15.34% and a return on equity of 20.66%. Procter & Gamble’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same quarter last year, the business earned $1.08 EPS. equities analysts expect that Procter & Gamble Co will post 4.21 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Thursday, February 15th. Shareholders of record on Friday, January 19th were issued a $0.6896 dividend. The ex-dividend date of this dividend was Thursday, January 18th. This represents a $2.76 dividend on an annualized basis and a yield of 3.49%. Procter & Gamble’s dividend payout ratio is currently 70.23%.
Several equities research analysts have commented on PG shares. Zacks Investment Research upgraded Procter & Gamble from a “hold” rating to a “buy” rating and set a $102.00 price objective for the company in a research note on Monday, January 8th. Goldman Sachs Group upgraded Procter & Gamble from a “sell” rating to a “neutral” rating and set a $77.00 price objective on the stock in a report on Tuesday, January 16th. Morgan Stanley upped their price objective on Procter & Gamble from $90.00 to $92.00 and gave the company an “equal weight” rating in a report on Thursday, January 25th. Deutsche Bank began coverage on Procter & Gamble in a research note on Tuesday, December 19th. They set a “buy” rating and a $91.88 price target on the stock. Finally, Wells Fargo & Co reaffirmed a “hold” rating and set a $88.00 price objective on shares of Procter & Gamble in a research report on Sunday, December 17th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $87.37.
COPYRIGHT VIOLATION NOTICE: “Procter & Gamble Co (PG) Stake Lessened by Family Legacy Inc.” was originally posted by The Lincolnian Online and is owned by of The Lincolnian Online. If you are accessing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark and copyright law. The legal version of this piece of content can be accessed at https://www.thelincolnianonline.com/2018/03/14/procter-gamble-co-pg-stake-decreased-by-family-legacy-inc.html.
Procter & Gamble Profile
The Procter & Gamble Company is focused on providing branded consumer packaged goods to the consumers across the world. The Company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care, and Baby, Feminine & Family Care. The Company sells its products in approximately 180 countries and territories primarily through mass merchandisers, grocery stores, membership club stores, drug stores, department stores, distributors, baby stores, specialty beauty stores, e-commerce, high-frequency stores and pharmacies.
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.